From: Novo Nordisk (mail@communications.novonordisk.com) Due to higher than anticipated demand, Novo Nordisk will be unable to provide the Sogroya 15 mg pen from Mid-February through May…
Read More
The use of glucagon-like-peptide-1 (GLP-1) receptor agonists for the treatment of obesity has increased significantly over the past year. Due to high demands and limited supply,…
Read More
Medication Shortage Alert – Pamidronate Disodium Injection: Anna Ryabets-Lienhard, DO, Drugs and Therapeutics Committee Update 10/25/23: As of August-September, there has been a national shortage of…
Read More
Novo Nordisk announced that due to significant demands, they are only able to supply limited quantities of 0.25 mg, 0.5 mg, and 1 mg dose strengths…
Read More
Calcium Carbonate (1250mg salt/500mg elemental calcium/5mL) suspension – national shortage. The date of shortage resolution is unknown at this time. For patients on oral therapy, alternatives…
Read More
March 2023: Pfizer announced a supply disruption of Pfizer’s Solu-Cortef® (hydrocortisone sodium succinate for injection, USP) 100 mg/2 mL (50 mg/mL) ACT-O[1]VIAL™ Single Dose Vial presentations…
Read More